Targeting the transcriptional kinases CDK12 and CDK13 in breast and ovarian cancer

被引：2
|
作者：
Bradley, Michael
Marineau, Jason
Choi, Yoon
Hamman, Kristin
Malojcic, Goran
Orlando, David
Ren, Yixuan
Ke, Nan
Hu, Shanhu
Olson, Eric
Fritz, Christian
Roberts, Christopher
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1143
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1143
引用
收藏
页数：2
相关论文
共 50 条
  • [21] 人类恶性肿瘤靶向治疗的新希望—CDK12/CDK13
    陈凯星
    武洲英
    俞兰
    肿瘤防治研究 , 2024, (05) : 386 - 391
  • [22] Characterizing CDK12 and CDK13 Activity in Transcription and mRNA Biogenesis in Mouse Embryonic Stem Cells
    Dubbury, Sara
    Sharp, Phillip
    FASEB JOURNAL, 2015, 29
  • [23] Cdk12 and Cdk13 regulate axonal elongation through a common signaling pathway that modulates Cdk5 expression
    Chen, Hong-Ru
    Lin, Guan-Ting
    Huang, Chun-Kai
    Fann, Ming-Ji
    EXPERIMENTAL NEUROLOGY, 2014, 261 : 10 - 21
  • [24] CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
    Tien, Jean Ching-Yi
    Luo, Jie
    Chang, Yu
    Zhang, Yuping
    Cheng, Yunhui
    Wang, Xiaoju
    Yang, Jianzhang
    Mannan, Rahul
    Mahapatra, Somnath
    Shah, Palak
    Wang, Xiao-Ming
    Todd, Abigail J.
    Eyunni, Sanjana
    Cheng, Caleb
    Rebernick, Ryan J.
    Xiao, Lanbo
    Bao, Yi
    Neiswender, James
    Brough, Rachel
    Pettitt, Stephen J.
    Cao, Xuhong
    Miner, Stephanie J.
    Zhou, Licheng
    Wu, Yi-Mi
    Labanca, Estefania
    Wang, Yuzhuo
    Parolia, Abhijit
    Cieslik, Marcin
    Robinson, Dan R.
    Wang, Zhen
    Feng, Felix Y.
    Chou, Jonathan
    Lord, Christopher J.
    Ding, Ke
    Chinnaiyan, Arul M.
    CELL REPORTS MEDICINE, 2024, 5 (10)
  • [25] CDK12: New breast and ovarian cancer predisposition gene in Tatar population?
    Shagimardanova, E.
    Brovkina, O.
    Gordiev, M.
    Enikeev, R.
    Shigapova, L.
    Khodyrev, D.
    Gusev, O.
    Kedrova, A.
    Kosiy, V.
    Nikitin, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] Lack of evidence for CDK12 as an ovarian cancer predisposing gene
    Alexandre Eeckhoutte
    Mathilde Saint-Ghislain
    Manon Reverdy
    Virginie Raynal
    Sylvain Baulande
    Guillaume Bataillon
    Lisa Golmard
    Dominique Stoppa-Lyonnet
    Tatiana Popova
    Claude Houdayer
    Elodie Manié
    Marc-Henri Stern
    Familial Cancer, 2020, 19 : 203 - 209
  • [27] Lack of evidence for CDK12 as an ovarian cancer predisposing gene
    Eeckhoutte, Alexandre
    Saint-Ghislain, Mathilde
    Reverdy, Manon
    Raynal, Virginie
    Baulande, Sylvain
    Bataillon, Guillaume
    Golmard, Lisa
    Stoppa-Lyonnet, Dominique
    Popova, Tatiana
    Houdayer, Claude
    Manie, Elodie
    Stern, Marc-Henri
    FAMILIAL CANCER, 2020, 19 (03) : 203 - 209
  • [28] Insights into the biological effect of targeting CDK12 in advanced ER plus breast cancer
    Allotta, A.
    Kalsi, S.
    Ola, M.
    Hickey, S.
    Cocchiglia, S.
    Bane, F.
    Sheehan, K.
    Vareslija, D.
    Young, L.
    Ottaviani, D.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 50 - 50
  • [29] Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery
    Liu, Hui
    Liu, Kangdong
    Dong, Zigang
    CANCER RESEARCH, 2021, 81 (01) : 18 - 26
  • [30] MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma
    Pitolli, Consuelo
    Marini, Alberto
    Guerra, Marika
    Pieraccioli, Marco
    Marabitti, Veronica
    Palluzzi, Fernando
    Giaco, Luciano
    Tamburrini, Gianpiero
    Cecconi, Francesco
    Nazio, Francesca
    Sette, Claudio
    Pagliarini, Vittoria
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
12345